Results 11 to 20 of about 5,401 (225)

Pimecrolimus in the clinical practice of a dermatologist [PDF]

Медицинский совет, 2022
Chronic inflammatory skin diseases are accompanied by the development of objective and subjective symptoms, which are manifested by erythema, edema, infiltration, accompanied by itching of varying severity.
N. M. Sharova, S. V. Kukalo
doaj   +2 more sources

Pimecrolimus cream in the management of patients with atopic eczema

Clinical, Cosmetic and Investigational Dermatology, 2009
Jonathan M SpergelDivision of Allergy and Immunology, The Children’s Hospital of Philadelphia Department of Pediatrics, University of Pennsylvania School of MedicineAbstract: Atopic eczema is a common pediatric skin disorder.
Jonathan M Spergel
doaj   +1 more source

Topical pimecrolimus for eczema

Cochrane Database of Systematic Reviews, 2007
Pimecrolimus was developed as an alternative to topical corticosteroids for treating eczema (atopic dermatitis) but its efficacy and safety compared with existing treatments remains unclear.To assess the effects of topical pimecrolimus for treating eczema.We searched the Cochrane Skin Group Specialised Register (to October 2006), the Cochrane Central ...
Ashcroft, Darren M.; id_orcid 0000-0002-2958-915X, Chen, L. C.; id_orcid 0000-0002-6158-6645, Garside, R., Stein, K., Williams, H. C.   +4 more
openaire   +3 more sources

PIMECROLIMUS CREAM IN CLINICAL PRACTICE OF CHILDREN'S ALLERGOLOGIST IMMUNOLOGIST

Педиатрическая фармакология, 2006
The object of the investigation was to estimate the basic therapy of atopic dermatitis (ad) in children and to analyze pimecrolimus application in clinical practice of children's allergologists immunologist.
L.M. Ogorodova, I.A. Deev, F.I. Petrovsky, V.A. Revyakina, S.V. Bychkovskaya, T.G. Golosova, N.V. Kazakevich, D.S. Korostovtsev, V.R. Lipina, I.V. Sidorenko, N.A. Smirnov, B.A. Chernyak   +11 more
doaj   +4 more sources

Pimecrolimus cream 1% in the management of atopic dermatitis in pediatric patients: a meta-analysis.

PLoS ONE, 2014
ObjectiveTo evaluate the efficacy and safety of pimecrolimus cream 1% in the treatment of AD in the pediatric population.MethodsPubMed, EMBASE, Web of Science and Cochrane library databases were searched till July 2013.
Chunyun Huang, Youyu Sheng
doaj   +2 more sources

EFFECTIVENESS AND SAFETY OF 1% PIMECROLIMUS CREAM AS APPLIED AMONG CHILDREN WITH ATOPIC DERMATITIS

Педиатрическая фармакология, 2009
The article highlights the findings of the open surveying uncontrolled multicentric postmarketing research to study the effectiveness and safety of 1% pimecrolimus cream as applied among children aged over months, suffering from atopic dermatitis.
K.E. Efendieva, Yu.G. Levina, L.S. Namazova-Baranova   +2 more
doaj   +3 more sources

Erosive pustulöse Dermatose der Unterschenkel (EPDL): Eine selten diagnostizierte neutrophile Dermatose älterer Menschen [PDF]

J Dtsch Dermatol Ges
Zusammenfassung Die erosive pustulöse Dermatose der Unterschenkel (EPDL) ist eine selten diagnostizierte, chronische entzündliche Hauterkrankung, die überwiegend bei älteren Menschen auftritt. Prädisponierende Faktoren sind unter anderem Hautatrophie, chronische venöse Insuffizienz und Traumata.
Dissemond J, Kottner J, Placke J, Erfurt‐Berge C.   +3 more
europepmc   +2 more sources

Successful Treatment of Localized Pemphigus Foliaceus with Topical Pimecrolimus [PDF]

Case Reports in Dermatological Medicine, 2013
We report the case of successful treatment of a 79-year-old male patient with recurrent pemphigus foliaceus with pimecrolimus cream 1% once daily for 40 days.
G. Tyros, K. Kalapothakou, E. Christofidou, A. Kanelleas, P. G. Stavropoulos   +4 more
doaj   +2 more sources

Use of Topical Tacrolimus and Topical Pimecrolimus in Four European Countries: A Multicentre Database Cohort Study [PDF]

Drugs - Real World Outcomes, 2018
BackgroundDespite the concerns about a potential increased risk of skin cancer and lymphoma with the use of topical tacrolimus and pimecrolimus, no population-based studies have given an overview of the use of these drugs in Europe.ObjectiveTo assess the
J. Kuiper, M. V. van Herk-Sukel, J. Castellsagué, A. Pottegård, I. A. Berglind, D. Dedman, L. Gutiérrez, B. Calingaert, J. Hallas, A. Sundström, A. Gallagher, J. Kaye, C. Pardo, K. Rothman, S. Perez-Gutthann   +14 more
semanticscholar   +2 more sources

Depigmentation Outcomes in Pigmented Oral Lichen Planus Managed With Mycophenolate Mofetil. [PDF]

Clin Case Rep
ABSTRACT Pigmented oral lichen planus (OLP) is a chronic, immune‐mediated mucosal disorder associated with dark black or brown discoloration secondary to the excess melanin deposition. This medical condition is often accompanied by the typical white (reticular) or red (erosive) OLP features and is refractory to conventional therapy. We report a case of
Biswas T, Bajoria AA, Nahar N, Sinha P, Sharan J, Basynat SKC.   +5 more
europepmc   +2 more sources